Cargando…
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
Obstructive airway diseases, e.g., chronic obstructive pulmonary disease (COPD) and asthma, represent leading causes of morbidity and mortality worldwide. However, the efficacy of currently available inhaled therapeutics is not sufficient for arresting disease progression and decreasing mortality, h...
Autores principales: | Xu, You, Thakur, Aneesh, Zhang, Yibang, Foged, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912103/ https://www.ncbi.nlm.nih.gov/pubmed/33525500 http://dx.doi.org/10.3390/pharmaceutics13020177 |
Ejemplares similares
-
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
por: Frederiksen, Lea Skak Filtenborg, et al.
Publicado: (2020) -
Nanoparticles for mucosal vaccine delivery
por: Thakur, Aneesh, et al.
Publicado: (2020) -
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
por: Wan, Qianyu, et al.
Publicado: (2023) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020)